摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(dimethylamino)hexanoic acid hydrochloride | 1191-27-1

中文名称
——
中文别名
——
英文名称
6-(dimethylamino)hexanoic acid hydrochloride
英文别名
6-(N,N-Dimethylamino)hexanoic acidhydrochloride;5-Carboxypentyl(dimethyl)azanium;chloride;5-carboxypentyl(dimethyl)azanium;chloride
6-(dimethylamino)hexanoic acid hydrochloride化学式
CAS
1191-27-1
化学式
C8H17NO2*ClH
mdl
——
分子量
195.689
InChiKey
IPGSZJSXPSBSMX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    104 °C

计算性质

  • 辛醇/水分配系数(LogP):
    1.61
  • 重原子数:
    12
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    6-(dimethylamino)hexanoic acid hydrochloride氯化亚砜 作用下, 以 氯仿 为溶剂, 反应 1.33h, 生成 octyl 6-dimethylaminohexanoate
    参考文献:
    名称:
    Hrabalek; Dolezal; Farsa, Pharmazie, 2000, vol. 55, # 10, p. 759 - 761
    摘要:
    DOI:
  • 作为产物:
    描述:
    6-methanesulfonyl-hexanoic acid ethyl ester 在 sodium hydroxide 作用下, 以 1,4-二氧六环乙醇 为溶剂, 反应 19.0h, 生成 6-(dimethylamino)hexanoic acid hydrochloride
    参考文献:
    名称:
    NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY
    摘要:
    本发明提供了一种新颖的、稳定的脂质颗粒,具有非层状结构,包括一种或多种活性剂或治疗剂,以及制备这种脂质颗粒的方法,以及传递和/或给予这种脂质颗粒的方法。更具体地,本发明提供了稳定的核酸脂质颗粒(SNALP),其具有非层状结构,包括核酸(如一种或多种干扰RNA),制备SNALP的方法,以及传递和/或给予SNALP的方法。
    公开号:
    US20160032320A1
点击查看最新优质反应信息

文献信息

  • FUSED HETEROCYCLIC COMPOUND AND MEDICINAL USE THEREOF
    申请人:Mitsubishi Pharma Corporation
    公开号:EP1396488A1
    公开(公告)日:2004-03-10
    The fused heterocyclic compound of the present invention, which is represented by the formula (I): wherein each symbol is as defined in the specification, an optically active form thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof and a water adduct thereof show poly(ADP-ribose) synthase inhibitory action and are useful as therapeutic drugs for cerebral infarction.
    本发明的融合杂环化合物,其化学式表示为(I):其中每个符号如规范中定义,其光学活性形式,其药学上可接受的盐,其水合物和水加合物显示聚(ADP-核糖)合酶抑制作用,并可用作治疗脑梗死的药物。
  • [EN] BRYOSTATIN ANALOGS AND USE THEREOF AS ANTIVIRAL AGENTS<br/>[FR] ANALOGUES DE LA BRYOSTATINE ET UTILISATION DE CEUX-CI EN TANT QU'AGENTS ANTIVIRAUX
    申请人:UNIV UTAH RES FOUND
    公开号:WO2016025363A1
    公开(公告)日:2016-02-18
    Described herein are tricyclic macrolactones. The macrolactones have a high binding affinity for PKC. The compounds described herein can be used in a number of therapeutic applications including the treatment or prevention of viral infection. Also described herein are methods for producing macrolactones. The methods permit the high-yield synthesis of macrolactones in a low number of steps and with a high degree of substitution and specificity.
    本文描述了三环大环内酯。这些大环内酯对蛋白激酶C(PKC)具有很高的结合亲和力。本文描述的化合物可用于多种治疗应用,包括治疗或预防病毒感染。本文还描述了生产大环内酯的方法。这些方法允许在较少的步骤中高产量地合成大环内酯,并具有高度的取代和特异性。
  • COMPOSITIONS AND METHODS FOR SILENCING APOLIPOPROTEIN B
    申请人:Heyes James
    公开号:US20130123339A1
    公开(公告)日:2013-05-16
    The present invention provides compositions and methods for the delivery of interfering RNAs such as siRNAs that silence APOB expression in cells such as liver cells. In particular, the nucleic acid-lipid particles provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells such as liver cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of APOB at relatively low doses. In addition, the compositions and methods of the present invention are less toxic and provide a greater therapeutic index compared to compositions and methods previously known in the art.
    本发明提供了一种用于传递干扰RNA(如siRNA)的组合物和方法,用于在细胞中(如肝细胞)沉默APOB表达。具体来说,核酸-脂质颗粒能够有效地封装核酸,并有效地将封装的核酸传递给体内的细胞,如肝细胞。本发明的组合物非常有效,因此可以在相对较低的剂量下有效地降低APOB的表达。此外,与先前已知的技术相比,本发明的组合物和方法毒性较低,并且提供了更大的治疗指数。
  • Automatic dishwashing compositions comprising multiquaternary bleach
    申请人:The Procter & Gamble Company
    公开号:US05520835A1
    公开(公告)日:1996-05-28
    Improved detergent compositions, especially granular automatic dishwashing detergents, comprising multiquaternary bleach activators are provided. The bleach activators contain multiple quaternary nitrogen groups, preferably at least three such groups and preferably have at least one quaternary nitrogen group in the peracid-forming portion of the bleach activator as well as at least one quaternary nitrogen group in the leaving-group portion.
    提供了改进的洗涤剂配方,特别是颗粒状自动洗碗洗涤剂,其中包含多季铵漂白活化剂。漂白活化剂含有多个季铵氮基团,最好至少有三个这样的基团,并且最好在漂白活化剂的过氧酸盐形成部分和离去基团部分至少各有一个季铵氮基团。
  • Fused heterocyclic compound and medicinal use thereof
    申请人:——
    公开号:US20040176361A1
    公开(公告)日:2004-09-09
    The fused heterocyclic compound of the present invention, which is represented by the formula (I): 1 wherein each symbol is as defined in the specification, an optically active form thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof and a water adduct thereof show poly(ADP-ribose) synthase inhibitory action and are useful as therapeutic drugs for cerebral infarction.
    本发明的融合杂环化合物,由式(I)表示:1其中每个符号如规范中所定义,其光学活性形式,其药学上可接受的盐,其水合物和水加合物均表现出聚(ADP-核糖)合酶抑制作用,并且可用作治疗脑梗塞的治疗药物。
查看更多